VIVO Meridian Bioscience Inc

Meridian Bioscience Inc is an integrated life science company. It is engaged in development, manufacture, sale and distribution of diagnostic test kits for certain gastrointestinal, viral, respiratory and parasitic infectious diseases.

$19.60  -0.16 (-0.81%)
As of 12/03/2021 15:59:57 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  03/09/2001
Outstanding shares:  43,364,448
Average volume:  637,280
Market cap:   $856,881,492
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    589584101
ISIN:        US5895841014
Sedol:      2580265
Valuation   (See tab for details)
PE ratio:   11.90
PB ratio:   2.64
PS ratio:   2.70
Return on equity:   21.75%
Net income %:   22.46%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy